Schonfeld Strategic Advisors LLC Mersana Therapeutics, Inc. Transaction History
Schonfeld Strategic Advisors LLC
- $15.4 Billion
- Q4 2024
A detailed history of Schonfeld Strategic Advisors LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 2,119,586 shares of MRSN stock, worth $1.1 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,119,586
Previous 2,223,308
4.67%
Holding current value
$1.1 Million
Previous $4.2 Million
27.87%
% of portfolio
0.02%
Previous 0.03%
Shares
20 transactions
Others Institutions Holding MRSN
# of Institutions
136Shares Held
101MCall Options Held
77.2KPut Options Held
453K-
Nextech Invest Ag12.1MShares$6.27 Million3.22% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.3MShares$5.89 Million0.76% of portfolio
-
Vr Adviser, LLC New York, NY10.3MShares$5.33 Million2.42% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$4.51 Million3.35% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$4.36 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $50.5M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...